Vectura Extends Novartis Deal For VR315 Lung Drug – Fox Business


Stockopedia

Vectura Extends Novartis Deal For VR315 Lung Drug
Fox Business
VX) for its generic asthma medicine VR315, covering markets outside Europe and North America. The deal follows hot on the heals of a US licensing agreement for the drug with an unnamed company earlier this week, and means Vectura has now licensed the
VECTURA GROUP PLC : VR315 RoW License Agreement4-traders (press release)
Vectura signs up Sandoz for asthma drug in RoW; good results for ALK Abello The Pharma Letter
Vectura agrees new licensing deal with Sandoz for asthma treatmentStockopedia

all 8 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.